Full Press Release Details
CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 2024 Annual Meeting.
CRSP
CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 2024 Annual Meeting
Key Takeaway: CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 2024 Annual Meeting
Price reaction · baseline $55.05 (2024-04-19 close) · clean, no other CRSP news in the window
day 0 close · peak
+1.1%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+60%
120-day peak, hindsight
Typical move
2.4%
average across 2 past catalysts
Cash runway
~84 mo
Minimal dilution risk
Lead asset
CTX340
Phase 1 · Hypertension